Current Management of Gastrointestinal Stromal Tumors (GIST) in the Region of Coquimbo

This study has been completed.
Sponsor:
Information provided by:
Cirujanos la Serena
ClinicalTrials.gov Identifier:
NCT00564265
First received: November 26, 2007
Last updated: August 9, 2011
Last verified: September 2010
  Purpose

This is a retrospective analysis and description of the preferred diagnostic and treatment methods employed on GIST on the Region of Coquimbo from 2003 to 2008.


Condition Intervention
Gastrointestinal Stromal Tumors
Other: Observation

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Outcomes of Surgical Treatment of Gastrointestinal Stromal Tumors in the IV Region of Chile

Resource links provided by NLM:


Further study details as provided by Cirujanos la Serena:

Primary Outcome Measures:
  • Number of Patients Who Survived [ Time Frame: 5 years ] [ Designated as safety issue: No ]
    The outcomes were measured through follow-up visits of the patients to the out-patient clinic of our institution at 15 days, 1 month, 3 months, 6 months, 1 year, and after that, every year after the surgical treatment.


Enrollment: 24
Study Start Date: January 2008
Study Completion Date: August 2008
Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
GIST
GIST from all gastrointestinal origins: esophagus, stomach, duodenum, jejunum, ileum, colon and rectum
Other: Observation
Not applied

  Eligibility

Ages Eligible for Study:   15 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

All patients operated on for GIST

Criteria

Inclusion Criteria:

  • All operated patients with GIST
  • Positive immunohistochemistry

Exclusion Criteria:

  • Patients with GIST not operated
  • Patients with GIST operated on but without immunohistochemistry
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00564265

Locations
Chile
Hospital De La Serena
La Serena, Coquimbo, Chile
Sponsors and Collaborators
Cirujanos la Serena
Investigators
Principal Investigator: Marcelo A Beltran, MD Hospital De La Serena
  More Information

Additional Information:
No publications provided

Responsible Party: Sobelcru Ltda
ClinicalTrials.gov Identifier: NCT00564265     History of Changes
Other Study ID Numbers: HLS-0047-11-07, 0047-11-07
Study First Received: November 26, 2007
Results First Received: November 3, 2008
Last Updated: August 9, 2011
Health Authority: Chile: Comisión Nacional de Investigación Científica y Tecnológica

Keywords provided by Cirujanos la Serena:
GIST

Additional relevant MeSH terms:
Gastrointestinal Stromal Tumors
Neoplasms, Connective Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms by Histologic Type
Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Digestive System Diseases
Gastrointestinal Diseases

ClinicalTrials.gov processed this record on August 27, 2014